In an era of economic uncertainty, the foundational pillars of financial planning are more critical than ever. Yet, a striking divide exists in the American landscape: according to LIMRA’s 2023 Insurance Barometer Study, only 52% of Americans possess some form of life insurance. For the remaining 48%, the absence of a policy represents a significant,…
New York, NY – As the summer season progresses, consumers are grappling with persistent financial questions, ranging from long-term wealth building to immediate protection against emerging threats. NerdWallet, a leading personal finance company, has highlighted three of the most trending queries from July, offering insights into the financial anxieties and aspirations of individuals across the…
According to LIMRA’s 2023 Insurance Barometer Study, a slim majority of Americans—52%—possess some form of life insurance coverage. For these individuals, the policy acts as a vital financial backstop, ensuring that their passing does not leave their families facing insurmountable debt or a sudden loss of living standards. However, the data reveals a stark reality:…
For the frequent flyer, the airport security experience is a calculated dance of efficiency. In recent years, the combination of TSA PreCheck and CLEAR has been heralded as the "gold standard" for bypassing the friction of domestic air travel. However, the economics of this convenience have shifted once again. As of July 1, 2026, CLEAR—the…
According to LIMRA’s 2023 Insurance Barometer Study, only 52% of Americans currently hold some form of life insurance coverage. While over half of the population can rest easier knowing their financial obligations will not become a burden to their surviving family members, a staggering 48% remain unprotected. For many, the hesitation to purchase a policy…
For years, Medicare beneficiaries seeking the groundbreaking GLP-1 medications for weight loss faced a definitive "no." However, a new initiative, dubbed the "Medicare GLP-1 Bridge short-term demonstration," is poised to change that narrative, albeit with significant caveats. Starting July 1, 2026, eligible individuals will gain access to certain GLP-1 drugs, like Wegovy (which shares the…
